In particular, IHC fails to detect mutants which encode unstable proteins (nonsense mutations, splicing mutations), which have been found in up to 47% of p53 mutations in breast tumours (Chappuis et al, 1999). This evidence concerns the gene TP53 and breast neoplasm.